For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Adiposity mediated the association between increased insulin resistance and cardiac damage among adolescents and young adults.

For patients with acute ischemic stroke, IV tenecteplase before endovascular thrombectomy is associated with higher functional independence at 90 days.

Hashimoto thyroiditis demonstrated a strong familial association between first-, second-, and third-degree relatives, especially among women.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.